AQR Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$350K Buy
66,065
+17,063
+35% +$105K ﹤0.01% 3327
2025
Q4
$378K Sell
49,002
-8,309
-14% -$74.1K ﹤0.01% 3061
2025
Q3
$506K Buy
57,311
+15,037
+36% +$112K ﹤0.01% 2802
2025
Q2
$175K Sell
42,274
-20,329
-32% -$127K ﹤0.01% 3079
2025
Q1
$377K Buy
62,603
+27,477
+78% +$168K ﹤0.01% 2577
2024
Q4
$182K Buy
35,126
+3,816
+12% +$15K ﹤0.01% 2692
2024
Q3
$93.6K Buy
+31,310
New +$85K ﹤0.01% 2662
2021
Q4
Sell
-2,466
Closed -$91K 2285
2021
Q3
$91K Buy
+2,466
New +$90.6K ﹤0.01% 2205
2019
Q2
Sell
-3,202
Closed -$114K 2193
2019
Q1
$114K Sell
3,202
-1,544
-33% -$61K ﹤0.01% 2127
2018
Q4
$191K Sell
4,746
-873
-16% -$53.3K ﹤0.01% 2088
2018
Q3
$489K Hold
5,619
﹤0.01% 1965
2018
Q2
$464K Buy
+5,619
New +$344K ﹤0.01% 2001
2014
Q3
Sell
-850
Closed -$92K 2595
2014
Q2
$92K Hold
850
﹤0.01% 2469
2014
Q1
$110K Hold
850
﹤0.01% 2506
2013
Q4
$116K Buy
+850
New +$112K ﹤0.01% 2507

Other funds holding VSTM

AQR Capital Management's VSTM Position: Q1 2026 in Review

AQR Capital Management increased its Verastem (VSTM) stake by 35% in Q1 2026, buying an estimated $105K and bringing the position to 66,065 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #3327.

AQR Capital Management first reported a position in VSTM in Q4 2013 and has held it in 15 quarters since. The position peaked at $506K in Q3 2025. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • AQR Capital Management held 66,065 shares of Verastem worth $350K as of Q1 2026.
  • AQR Capital Management bought 17,063 Verastem shares in Q1 2026, an estimated $105K.
  • Verastem made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3327 holding.
  • AQR Capital Management first reported a position in Verastem in Q4 2013 and has held it in 15 quarters since.
  • AQR Capital Management's Verastem position peaked at $506K in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.